amfAR Funds $20m Institute For HIV Cures; Gilead To Collaborate
This article was originally published in Scrip
Executive Summary
The Foundation for AIDS Research, better known as amfAR, will provide $20m over five years to establish the amfAR Institute for HIV Cure Research at the University of California, San Francisco (UCSF), and Gilead Sciences Inc. is one of several collaborators in the project.